Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-04-22 @ 3:50 AM
Study NCT ID:
NCT02832167
Status:
COMPLETED
Last Update Posted:
2022-05-09
First Post:
2016-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-08
First Submit QC Date:
None
Study First Post Date:
2016-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-20
Results First Submit QC Date:
None
Results First Post Date:
2020-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-06
Last Update Post Date:
2022-05-09
Last Update Post Date Type:
ACTUAL